PTHR10373: Difference between revisions
Jump to navigation
Jump to search
Line 17: | Line 17: | ||
==Molecular Function== | ==Molecular Function== | ||
*Based on the definition, shouldn't GO:0003705 "sequence-specific enhancer binding RNA polymerase II transcription factor activity" have some sort of relationship, either is_a or has_part, GO:0035326 "enhancer binding"? | *Based on the definition, shouldn't GO:0003705 "sequence-specific enhancer binding RNA polymerase II transcription factor activity" have some sort of relationship, either is_a or has_part, GO:0035326 "enhancer binding"? | ||
==Biological Process== | ==Biological Process== |
Revision as of 13:42, 5 August 2011
This is a list of questions that arose while PAINTing PTHR_____.
Questions for MOD curators
Molecular Function
Human LEF1
- Question: Is the IMP to GO:0043027 "caspase inhibitor activity" in PMID 20360943 appropriate? Does the experiment really show a biochemical interaction between LEF1 and caspase, or is reduction of caspase activity aresult of mutating LEF1? If the latter, shouldn't that be a BP annotation?
- Curator answer: Insert answer here.
- Question: Does LEF1 really bind estrogen, as the GO:0030284 "estrogen receptor activity" IDA from PMID 18794125 implies? How could LEF1 have both "estrogen receptor activity" and "estrogen receptor binding" activity (from the same paper)?
- Curator answer: Insert answer here.
Organism(s) 2
Cellular Component
Biological Process
Questions for ontology curators
Molecular Function
- Based on the definition, shouldn't GO:0003705 "sequence-specific enhancer binding RNA polymerase II transcription factor activity" have some sort of relationship, either is_a or has_part, GO:0035326 "enhancer binding"?